BRIEF-Amphastar Pharmaceuticals Q3 EPS USD 0.87
Reuters2026/11/05 21:12Nov 05 (Reuters) - Amphastar Pharmaceuticals Q3 adjusted EPS USD 1.14 vs. IBES estimate USD 0.86.
- Q3 revenue USD 207.608 million vs. IBES estimate USD 197.9 million
- Q3 net income USD 37.763 million
- Q3 adjusted net income USD 49.265 million vs. IBES estimate USD 37.9 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
After acquiring SpotHero, Uber (UBER.US) makes its debut in the parking sector with a parking space reservation feature, initially available in 15 U.S. cities
Uber has launched a brand new parking space reservation feature, which marks its first step in the parking sector following its acquisition of the parking app SpotHero earlier this year.
Crypto prices
More
